Education
About Us
Working with TipRanks
Follow Us
Cryo-Cell International Inc (CCEL)
:CCEL
Total Valuation
Cryo-Cell International has a market cap or net worth of $35.04M. The enterprise value is $47.32M.
Market Cap$35.04M
Enterprise Value$47.32M
Share Statistics
Cryo-Cell International has 8,055,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,055,150
Owned by Insiders35.64%
Owned by Institutions5.08%
Financial Efficiency
Cryo-Cell International’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is 1.06%.
Return on Equity (ROE)-0.03
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)1.06%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee390.07K
Profits Per Employee4.90K
Employee Count82
Asset Turnover0.49
Inventory Turnover12.08
Valuation Ratios
The current PE Ratio of Cryo-Cell International is ―. Cryo-Cell International’s PEG ratio is -1.68.
PE Ratio―
PS Ratio2.20
PB Ratio-5.33
Price to Fair Value-5.33
Price to FCF19.54
Price to Operating Cash Flow5.52
PEG Ratio-1.68
Income Statement
In the last 12 months, Cryo-Cell International had revenue of 31.99M and earned 402.10K in profits. Earnings per share was 0.05.
Revenue31.99M
Gross Profit24.04M
Operating Income3.48M
Pretax Income2.80M
Net Income402.10K
EBITDA1.42M
Earnings Per Share (EPS)0.05
Cash Flow
In the last 12 months, operating cash flow was 6.35M and capital expenditures -304.93K, giving a free cash flow of 6.05M billion.
Operating Cash Flow6.35M
Free Cash Flow6.05M
Free Cash Flow per Share0.75
Dividends & Yields
Cryo-Cell International pays an annual dividend of $0.15, resulting in a dividend yield of 8.86%
Dividend Per Share$0.15
Dividend Yield8.86%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.02
52-Week Price Change-34.13%
50-Day Moving Average4.56
200-Day Moving Average5.44
Relative Strength Index (RSI)49.39
Average Volume (3m)19.02K
Important Dates
Cryo-Cell International upcoming earnings date is Feb 26, 2026, TBA (Confirmed).
Last Earnings DateOct 15, 2025
Next Earnings DateFeb 26, 2026
Ex-Dividend DateMay 21, 2025
Financial Position
Cryo-Cell International as a current ratio of 0.58, with Debt / Equity ratio of -28.40%
Current Ratio0.58
Quick Ratio0.55
Debt to Market Cap0.17
Net Debt to EBITDA8.70
Interest Coverage Ratio1.87
Taxes
In the past 12 months, Cryo-Cell International has paid 2.40M in taxes.
Income Tax2.40M
Effective Tax Rate0.86
Enterprise Valuation
Cryo-Cell International EV to EBITDA ratio is 58.23, with an EV/FCF ratio of 22.97.
EV to Sales2.59
EV to EBITDA58.23
EV to Free Cash Flow22.97
EV to Operating Cash Flow13.79
Balance Sheet
Cryo-Cell International has $3.22M in cash and marketable securities with $4.21M in debt, giving a net cash position of -$990.36K billion.
Cash & Marketable Securities$3.22M
Total Debt$4.21M
Net Cash-$990.36K
Net Cash Per Share-$0.12
Tangible Book Value Per Share-$1.98
Margins
Gross margin is 77.07%, with operating margin of 10.88%, and net profit margin of 1.26%.
Gross Margin77.07%
Operating Margin10.88%
Pretax Margin8.77%
Net Profit Margin1.26%
EBITDA Margin4.45%
EBIT Margin2.94%
Analyst Forecast
The average price target for Cryo-Cell International is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-0.29%
EPS Growth Forecast94.56%